Stock To Watch: Here's Why You Need To Keep An Eye On Kala Pharma (KALA)

Shares of Kala Pharmaceuticals Inc. (KALA) have gained over 10 percent in the last 5 trading days as the Company gears up to report results from STRIDE 3 - a phase III clinical trial for EYSUVIS, its product candidate for the short-term treatment of dry eye disease, this month.

from RTT - Biotech https://ift.tt/38q9SKy
via IFTTT